NCI Community Oncology Research Program (NCORP)



Attachment 1: Accrual Cancer Control, Prevention, Treatment or Imaging Trials (use filename: Accrual_CPTI). Table 1a. Accrual to NCI-sponsored cancer control, prevention, screening, biospecimen, and treatment trials during the past 5 years. Study Type1Lead OrganizationTrial Number & Brief TitleNumber of AccrualsTotal Accrual2 2014 2015201620172018Example: CCAllianceA011104, Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast CancerN/A137213 Example: BNational Cancer Institute9846, Patient-Derived Models Tissue Procurement Protocol for the National Cancer InstituteN/AN/A3101141 List by study type first, then by organization. Indicate Study Type as CC (cancer control including symptom management), or P (primary endpoint is prevention), or S (screening/surveillance), or B (biospecimen focused only on blood and/or tissue acquisition), or T (treatment/imaging trials). Organizations should be grouped together (i.e., one organization followed by another such as Alliance, followed by COG, then ECOG-ACRIN, etc.)2 Total accrual should be sum of the specified trial accrual for the five year period. Table 1b. Accrual to studies sponsored by other organizations1 during the past 5 years.Study Type2Lead OrganizationTrial Number & Brief TitleNumber of AccrualsTotal Accrual3 2014 2015201620172018Example: CCAlliance FoundationAFT 25, Comparison of Operative to Monitoring and Endocrine Therapy for Low Risk DCIS: COMETN/AN/AN/A235Example: TAmerican Society of Clinical OncologyTargeted Agent and Profiling Utilization Registry (TAPUR)N/AN/AN/A5491 Other organizations include trials sponsored by organizations other than the NCI such as NCTN Group foundations, industry/pharmaceutical, non-profit organizations, investigator initiated, etc. 2 List by study type first, then by organization. Indicate Study Type as CC (cancer control including symptom management), or P (primary endpoint is prevention), or S (screening/surveillance), or B (biospecimen focused only on blood and/or tissue acquisition), or T (treatment/imaging trials). Organizations should be grouped together (i.e., one organization followed by another such as Alliance, followed by COG, then ECOG-ACRIN, etc.)3 Total accrual should be sum of the specified trial accrual for the five year period. Attachment 2: Accrual to Cancer Care Delivery Research Studies (use filename: Accrual CCDR). For New and Renewal applications: In this attachment, provide documentation of accrual to closed and ongoing NCI-sponsored cancer care delivery research studies, if applicable, and to cancer care delivery studies sponsored by other organizations (e.g. American Cancer Society, Patient-Centered Outcomes Research Institute), during the past 5 years. Accrual figures should include the unique number of patients, non-patients, and/or organizations/practices enrolled on each NCORP study, as appropriate. The table should have column headings for the table should include the 1) lead organization, 2) trial number and brief title, 3) study type, 4) denote whether the study is multilevel, 5) accrual category, 6) number of accruals per year, and 7) total column summing accrual by category for the 5-year period. Please use additional rows to summarize accrual for multilevel studies. Lead OrganizationTrial Number & Brief TitleStudy Type1 Multilevel2(mark)Accrual Category3Number of AccrualsTotal Accrual4 2014 2015201620172018Example: NCORP RBA231601CD: Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of an Efficient Pre-Surgical Toolkit (OPTI-Surg)INT?Organization/Practice10N/AN/AN/A10Example: NCORP RBA231601CD: Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of an Efficient Pre-Surgical Toolkit (OPTI-Surg)INT?ClinicianN/AN/A35412Example: NCORP RBA231601CD: Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of an Efficient Pre-Surgical Toolkit (OPTI-Surg)INT?Patient20151481168Example: American Cancer SocACS12345: Assessing Multiple Myeloma Outcomes with Nurse Navigation in Primary CareOBS?Clinician64587301 Indicate Study Type as OBS (for observational studies in which patients, non-patients, and/or organizations/practices are observed or certain outcomes are measured) or INT (for interventional studies that evaluate the effects of delivery, processes, management, or organization of patient, non-patient, and/or organization/practice factors on clinical outcomes and patient well-being).2Mark the Multi-level box if the study is evaluating interventions at multiple levels of the health care system, such as the provider and the patient, patient and the organization, provider and organization, or all three; the primary aim may be on one of the levels but there may be interventions at multiple levels.3The accrual category for each reported cancer care delivery research study may include patients, non-patients (e.g. caregivers, physicians, nurses, pharmacists), and/or organizations/practices, as appropriate. Please use additional rows to summarize accrual for each accrual category.4Total accrual should be the sum of patients, non-patients, and/or organizations/practices for the five year period.Attachment 3: Collective Bodies/Committees Essential for Community Site Functions (use filename: Committee Memberships).Table 3. Applicant Member Participation in Community-Based Research EffortsName of IndividualCollective Body Category1Member Status2Length of Service 1 Examples: oversight board, steering committee, NCTN Group/NCORP Research Base committee, NCI advisory board/committee, etc.2 Examples: Chair, Vice Chair, Co-Chair, community representative, committee member, etc. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download